In a breakthrough animal experiment (15), it was found that ICAM-1 CAR-T cells that target intercellular adhesion molecule-1 can mediate strong and lasting anti-tumor activity, leading to tumor eradication and a significant increase in the long-term survival of ATC xenograft mouse models. Here, ICAM1 is linked to neoplasm.